Thanks for posting this rj. It’s a tremendous blessing that Joel was able to be treated with $NWBO #DCVax-L. I’m looking forward to the #MHRA approving this treatment so more solid tumor cancer patients in the UK & around the world can also be treated with DCVax like

$NWBO - asgct.org/global/documen…

Buckle up. The $NWBO discovery battle against seven of the largest market makers, including Virtu Financial and Citadel Securities, has begun.

#dcvax $nwbo #gbm Linda Liau is an invited speaker at the 2025 Annual meeting of TNS (Taiwan Neurosurgical Society) on the 20-21 December, 2025 - Program details 'coming soon' Linda M. LIAU, MD, PhD, MBA USA Chair, Department of Neurosurgery, UCLA Professor and Director,

$NWBO 🧵 In Vivo T Cell Activation The DCVax-Direct Approach Most cell therapies reprogram T cells in a lab. DCVax-Direct does it differently: it trains the immune system inside the tumor, where the battle is actually happening. Here’s how it works 👇 🧬 DCVax-Direct |

Laugh $NWBO That’s a very good question and the answer reinforces how rare rejection would be at this stage. Once a drug is listed under the UK Specials or IFR (Individual Funding Request) programs, it’s typically because the MHRA already acknowledges a clinical benefit, especially

#dcvax $nwbo #gbm Inside the Latest Research Advancements to Help Combat Brain Cancer : Investigators at the UCLA Health Jonsson Comprehensive Cancer Center are developing new strategies to better understand and treat one of the most challenging forms of cancer. “While

You’re right‼️Both UCLA & Roswell Park have researched & developed next-generation combination treatments that are complementary to & synergistic with $NWBO #DCVax dendritic cell vaccine platform. DCVax will eventually help millions of solid tumor cancer patients live longer.

FDA’s Conditional Approval Plan Would Unleash Biotech Innovation forbes.com/sites/greglich… “We’re going to be rolling out a new pathway for drugs, which is a pathway based on a plausible mechanism,” This is exactly what $NWBO needs to make DCVax-L available for patients suffering

ATLnsider Thanks ATLnsider what you just laid out is profound. The science was so advanced, even the inventors didn’t fully realize how deep it went. $NWBO knew it worked. They knew it was dendritic cell–based. But they didn’t yet completely know why it worked this well. And in drug

NWBO defendants wants to hide who hired them to manipulate and Spoof NWBO Could a criminal do that? youtu.be/Gaa8dcMqxgE Criminal Division U.S. Securities and Exchange Commission FBI US Attorney SDNY Gary Gensler Adam Aron Elizabeth Warren MSNBC Charles V Payne Financial Times The Associated Press CNN

The topic of Alessandra De Riva, from Advent Bioservices, talk at the Cell & Gene Therapy Summit 2025, on 7/8/2025 is very interesting for $NWBO #DCVax-L: “From Development to Commercialisation : What is the Key to Success? This bodes well for DCVax-L approval by MHRA soon:

JaredT it does appear like NWBO is trying to quickly obtain the MM's customers identities so NWBO can subpoena said customers as soon as possible

Here’s another nice article about Dr. Linda Liau & her work with helping to develop & research $NWBO #DCVax. Article also highlights fact DCVax-L has resulted in increased survival for Glioblastoma (GBM) & has doubled 5-Year overall survival (OS) rate for GBM patients:

FUDsters, manipulators & liars say that Dr. Linda Liau said FDA will require $NWBO provide patient-level data for its External Control Arm (ECA). But, that’s not true because NWBO didn’t use any real world data (RWD) or real world evidence (RWE) in its ECA: